Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry researchers · Saturday, August 24, 2024 · 737,963,004 Articles · 3+ Million Readers

Bovine Lactoferrin Market Set to Double by 2031 with 7.8% CAGR Growth

Bovine Lactoferrin Market Size, Share

Bovine Lactoferrin Market Size, Share

PORTLAND, OREGON, UNITED STATES, August 23, 2024 /EINPresswire.com/ -- The global bovine lactoferrin market, valued at $353.3 million in 2021, is poised for significant growth, projected to reach $750.9 million by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% from 2022 to 2031. Bovine lactoferrin, a protein derived from bovine milk, plays a critical role in iron absorption, immune system enhancement, and protection against infections. Its broad applications, particularly in dietary supplements and infant nutrition, are driving this market's expansion.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

𝑺𝒚𝒏𝒍𝒂𝒊𝒕 𝑴𝒊𝒍𝒌 𝑳𝒕𝒅, 𝑼𝑺 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍𝒔, 𝑻𝒂𝒕𝒖𝒂 𝑪𝒐-𝑶𝒑𝒆𝒓𝒂𝒕𝒊𝒗𝒆 𝑫𝒂𝒊𝒓𝒚 𝑪𝒐𝒎𝒑𝒂𝒏𝒚 𝑳𝒕𝒅, 𝑩𝒆𝒈𝒂 𝑪𝒉𝒆𝒆𝒔𝒆 𝑳𝒊𝒎𝒊𝒕𝒆𝒅, 𝑺𝒂𝒑𝒖𝒕𝒐, 𝑰𝒏𝒄 (𝑺𝒂𝒑𝒖𝒕𝒐 𝑫𝒂𝒊𝒓𝒚 𝑨𝒖𝒔𝒕𝒓𝒂𝒍𝒊𝒂 𝑷𝒕𝒚 𝑳𝒕𝒅.), 𝑺𝒂𝒗𝒆𝒏𝒄𝒊𝒂 𝑺𝒂 (𝑨𝒓𝒎𝒐𝒓 𝑷𝒓𝒐𝒕𝒆𝒊𝒏𝒆𝒔), 𝑩𝒆𝒔𝒕𝒐𝒏 𝑮𝒍𝒐𝒃𝒂𝒍 𝑭𝒐𝒐𝒅 𝑪𝒐𝒎𝒑𝒂𝒏𝒚 𝑳𝒕𝒅, 𝑱𝒂𝒓𝒓𝒐𝒘 𝑭𝒐𝒓𝒎𝒖𝒍𝒂𝒔, 𝑰𝒏𝒄, 𝑵𝒖𝒕𝒓𝒊𝒔𝒄𝒊𝒆𝒏𝒄𝒆 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏𝒔, 𝑳𝒍𝒄, 𝑭𝒐𝒏𝒕𝒆𝒓𝒓𝒂 𝑪𝒐-𝑶𝒑𝒆𝒓𝒂𝒕𝒊𝒗𝒆 𝑮𝒓𝒐𝒖𝒑 𝑳𝒊𝒎𝒊𝒕𝒆𝒅, 𝑴𝒐𝒓𝒊𝒏𝒂𝒈𝒂 & 𝑪𝒐., 𝑳𝒕𝒅 (𝑴𝒐𝒓𝒊𝒏𝒂𝒈𝒂 𝑴𝒊𝒍𝒌 𝑰𝒏𝒅𝒖𝒔𝒕𝒓𝒚), 𝑵𝒐𝒖𝒎𝒊 𝑳𝒊𝒎𝒊𝒕𝒆𝒅 (𝑭𝒓𝒆𝒆𝒅𝒐𝒎 𝑭𝒐𝒐𝒅𝒔 𝑷𝒕𝒚 𝑳𝒊𝒎𝒊𝒕𝒆𝒅), 𝑶𝒔𝒌𝒊𝒂 𝑺𝒌𝒊𝒏𝒄𝒂𝒓𝒆 𝑳𝒕𝒅, 𝑮𝒍𝒂𝒏𝒃𝒊𝒂 𝑷𝒍𝒄, 𝑳𝒂 𝑷𝒓𝒐𝒔𝒑𝒆𝒓𝒊𝒕𝒆 𝑭𝒆𝒓𝒎𝒊𝒆𝒓𝒆 𝑺𝒐𝒄𝒊𝒆𝒕𝒆 𝑪𝒐𝒐𝒑𝒆𝒓𝒂𝒕𝒊𝒗𝒆 𝑨𝒈𝒓𝒊𝒄𝒐𝒍𝒆 (𝑰𝒏𝒈𝒓𝒆𝒅𝒊𝒂 𝑵𝒖𝒕𝒓𝒊𝒐𝒏𝒂𝒍), 𝑹𝒐𝒚𝒂𝒍 𝑭𝒓𝒊𝒆𝒔𝒍𝒂𝒏𝒅 𝑪𝒂𝒎𝒑𝒊𝒏𝒂 𝑵.𝑽., 𝑰𝒏𝒏𝒆𝒓 𝑴𝒐𝒏𝒈𝒐𝒍𝒊𝒂 𝒀𝒊𝒍𝒊 𝑰𝒏𝒅𝒖𝒔𝒕𝒓𝒊𝒂𝒍 𝑮𝒓𝒐𝒖𝒑 𝑪𝒐., 𝑳𝒕𝒅 (𝑾𝒆𝒔𝒕𝒍𝒂𝒏𝒅 𝑴𝒊𝒍𝒌)

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/A17094

Catalysts for Market Growth

Several factors are propelling the bovine lactoferrin market forward. The rising global demand for dietary supplements and nutrient-rich foods is a primary driver. As health-conscious consumers seek products that boost immunity and overall wellness, bovine lactoferrin's popularity is on the rise. Moreover, the growing number of working mothers worldwide has spurred demand for infant nutrition products fortified with bovine lactoferrin, further contributing to market growth.

Clinical research has also highlighted bovine lactoferrin's effectiveness in treating various skin conditions, such as acne, and its potential applications in pharmaceuticals, personal care, and as an antiviral and anti-inflammatory agent. These findings have encouraged market players to innovate and introduce new products, thereby expanding the market's reach.

Challenges and Opportunities

Despite its promising outlook, the bovine lactoferrin market faces certain challenges. The promotion of breastfeeding practices, which naturally reduces the demand for infant formula, is a significant restraint. However, this challenge is counterbalanced by the ongoing development of cost-effective manufacturing techniques, which presents a lucrative opportunity for market expansion.

Market Segmentation and Regional Insights

The bovine lactoferrin market is segmented by product type, application, function, and region. Among product types, freeze-dried powder generated the most revenue in 2021, due to its extended shelf life and preservation of functional properties. However, the spray-dried powder segment is expected to grow at the fastest rate, with a projected CAGR of 8.3% during the forecast period, driven by lower manufacturing costs.

In terms of application, infant nutrition dominated the market in 2021, reflecting the segment's critical role in boosting infant immunity. The dietary supplement segment is anticipated to experience the highest growth, with a CAGR of 8.2%, fueled by the increasing demand for products with antibacterial, anti-inflammatory, and antiviral properties.

Functionally, the iron absorption segment led the market in 2021, largely due to its benefits for anemic individuals and pregnant women. However, the immune cell stimulation segment is expected to grow at the fastest rate, with a CAGR of 8.55%, owing to its potential in prophylactic and therapeutic applications.

Regionally, North America held the largest market share in 2021, driven by technological advancements and the presence of key market players. The Asia-Pacific region, however, is poised for notable growth, supported by rising infant and anemic populations, improved healthcare infrastructure, and increased investment in the sector.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A17094

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

Powered by EIN Presswire

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release